Outcome measurement for gender-affirming care in Canada: a systematic review

被引:0
作者
Jackman, Liam [1 ]
Chan, Cynthia [2 ]
Garvilles, Micon [3 ]
Kamran, Rakhshan [3 ]
机构
[1] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[2] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[3] Univ Oxford Nuffield, Dept Orthopaed Rheumatol & Musculoskeletal Sci, Oxford, England
来源
BMJ OPEN | 2025年 / 15卷 / 03期
关键词
Clinical Decision-Making; Health Equity; Health Services; Quality in healthcare; Health Services for Transgender Persons; PATIENT-REPORTED OUTCOMES; HUMAN GLANDULAR KALLIKREIN; PROSTATE-SPECIFIC ANTIGEN; FERTILITY PRESERVATION; CYPROTERONE-ACETATE; TRANSGENDER MAN; TESTOSTERONE; SATISFACTION; THERAPY; SPIRONOLACTONE;
D O I
10.1136/bmjopen-2024-091135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Gender-affirming care (GAC) includes interventions aimed at supporting an individual's gender identity. Canada is experiencing an increase in referrals for GAC, higher than any other health service; therefore, there is a need for a systematic approach to health outcome measurement to effectively evaluate care. This review aims to analyse health outcome measurement in Canadian GAC, focusing on what is measured, how it is measured and associated barriers and enablers.Methods A comprehensive search was conducted in MEDLINE, Embase, PsycINFO, Scopus and CINAHL, up to 26 December 2023. Inclusion criteria were original articles involving transgender or gender-diverse (TGD) patients receiving gender-affirming care in Canada.Results A total of 4649 articles were identified with 64 included, representing 6561 TGD patients. Most studies were conducted in Ontario (52%), British Columbia (19%) and Quebec (11%). The most common forms of GAC provided were hormonal (36%) and surgical (27%). Barriers to outcome measurement include that most studies (61%) did not use patient-reported outcome measures (PROMs). When PROMs were used, most did not capture gender-related constructs (eg, gender dysphoria). Barriers to accessing care included stigma, discrimination, lack of clinician knowledge, geographic, socioeconomic and institutional barriers.Conclusion This review reveals gaps in outcome measurement for GAC, particularly underutilisation of PROMs and inconsistent outcome measurement and reporting. There is a need to systematically implement PROMs, including those measuring gender-related constructs, to promote patient-centred care. This review provides evidence-based recommendations for improving health outcomes for TGD individuals in Canada.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Gender-affirming care and endocrine-related cancers
    Harty, Roger
    Safer, Joshua D.
    ENDOCRINE-RELATED CANCER, 2024, 31 (02)
  • [22] Preventing transition "regret": An institutional ethnography of gender-affirming medical care assessment practices in Canada
    MacKinnon, K. R.
    Ashley, F.
    Kia, H.
    Lam, J. S. H.
    Krakowsky, Y.
    Ross, L. E.
    SOCIAL SCIENCE & MEDICINE, 2021, 291
  • [23] Access to Gender-Affirming Care and Transgender Mental Health
    Mann, Samuel
    Campbell, Travis
    Nguyen, Duc Hien
    AMERICAN JOURNAL OF HEALTH ECONOMICS, 2024, 10 (02) : 162 - 181
  • [24] Considerations of gender-affirming care for transgender and gender-diverse youth
    Mills, Alex R.
    Astle, Kevin N.
    Aragon, Kelsea Gallegos
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2024, 81 (19) : E640 - E647
  • [25] Mental health and quality of life outcomes of gender-affirming surgery: A systematic literature review
    Swan, Jaime
    Phillips, Tania M.
    Sanders, Tait
    Mullens, Amy B.
    Debattista, Joseph
    Bromdal, Annette
    JOURNAL OF GAY & LESBIAN MENTAL HEALTH, 2023, 27 (01) : 2 - 45
  • [26] Gender-affirming hormone therapy: An updated literature review with an eye on the future
    D'hoore, Laurens
    T'Sjoen, Guy
    JOURNAL OF INTERNAL MEDICINE, 2022, 291 (05) : 574 - 592
  • [27] Gender-Affirming Hormone Therapy for Transgender Men
    Moravek, Molly B.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2018, 61 (04) : 687 - 704
  • [28] The Effect of Gender-Affirming Hormones on Gender Dysphoria, Quality of Life, and Psychological Functioning in Transgender Individuals: A Systematic Review
    van Leerdam, Taylah R.
    Zajac, Jeffrey D.
    Cheung, Ada S.
    TRANSGENDER HEALTH, 2023, 8 (01) : 6 - 21
  • [29] The Effect of Gender-Affirming Hormone Therapy on the Risk of Subclinical Atherosclerosis in the Transgender Population: A Systematic Review
    Allgayer, Roberta M. C. Moreira
    Borba, Gustavo da Silva
    Moraes, Ruy Silveira
    Ramos, Ramon Bossardi
    Spritzer, Poli Mara
    ENDOCRINE PRACTICE, 2023, 29 (06) : 498 - 507
  • [30] Gender-affirming estrogen therapy route of administration and cardiovascular risk: a systematic review and narrative synthesis
    Miranda, Keila Turino
    Kalenga, Cindy Z.
    Saad, Nathalie
    Dumanski, Sandra M.
    Collister, David
    Rytz, Chantal L.
    Lorenzetti, Diane L.
    Chang, Danica H.
    McClurg, Caitlin
    Sola, Darlene Y.
    Ahmed, Sofia B.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2022, 323 (05): : H861 - H868